Interstitial Lung Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease
Conditions:   Interstitial Lung Disease;   Chronic Kidney Diseases Interventions:   Biological: AD-214;   Other: Placebo Sponsor:   AdAlta Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
Condition:   Progressive Fibrosing Interstitial Lung Disease Intervention:   Diagnostic Test: Hyperpolarized xenon-129 MRI Sponsors:   University of Aarhus;   Aarhus University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease
Conditions:   Interstitial Lung Disease;   Chronic Kidney Diseases Interventions:   Biological: AD-214;   Other: Placebo Sponsor:   AdAlta Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
Condition:   Progressive Fibrosing Interstitial Lung Disease Intervention:   Diagnostic Test: Hyperpolarized xenon-129 MRI Sponsors:   University of Aarhus;   Aarhus University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease
Conditions:   Interstitial Lung Disease;   Chronic Kidney Diseases Interventions:   Biological: AD-214;   Other: Placebo Sponsor:   AdAlta Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
Condition:   Progressive Fibrosing Interstitial Lung Disease Intervention:   Diagnostic Test: Hyperpolarized xenon-129 MRI Sponsors:   University of Aarhus;   Aarhus University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease
Conditions:   Interstitial Lung Disease;   Chronic Kidney Diseases Interventions:   Biological: AD-214;   Other: Placebo Sponsor:   AdAlta Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
Condition:   Progressive Fibrosing Interstitial Lung Disease Intervention:   Diagnostic Test: Hyperpolarized xenon-129 MRI Sponsors:   University of Aarhus;   Aarhus University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease
Conditions:   Interstitial Lung Disease;   Chronic Kidney Diseases Interventions:   Biological: AD-214;   Other: Placebo Sponsor:   AdAlta Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
Condition:   Progressive Fibrosing Interstitial Lung Disease Intervention:   Diagnostic Test: Hyperpolarized xenon-129 MRI Sponsors:   University of Aarhus;   Aarhus University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease
Conditions:   Interstitial Lung Disease;   Chronic Kidney Diseases Interventions:   Biological: AD-214;   Other: Placebo Sponsor:   AdAlta Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
Condition:   Progressive Fibrosing Interstitial Lung Disease Intervention:   Diagnostic Test: Hyperpolarized xenon-129 MRI Sponsors:   University of Aarhus;   Aarhus University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Condition:   Interstitial Lung Disease Interventions:   Drug: efzofitimod 450 mg;   Drug: efzofitimod 270 mg;   Drug: Placebo Sponsor:   aTyr Pharma, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials